DMD drug development program

Two Web-based, industry-sponsored presentations that update the Duchenne MD community about exon-skipping drug development will take place Oct. 15 and Oct. 17

posted on October 11, 2013 - 11:13am
Pharmaceutical companies developing exon-skipping drugs for Duchenne muscular dystrophy (DMD) will host Web-based presentations for the DMD community during the week of Oct. 14, 2013. GSK, Prosensa to present Oct. 15

New content is being added every day. Please check back again.